Anti-seizure medications are not a cure, and about 30% of people with epilepsy don't respond to them. How are new medications discovered, and what's on the horizon?
A team led by engineers at the University of California San Diego has developed a device that is a first step to enabling noninvasive, ultrasound-based therapies for the brain. For example, ultrasound waves are currently being used in clinical trials to treat epilepsy.
A new study from an international team of researchers — including two from Binghamton University — demonstrates that social media could be used to detect behaviors preceding sudden unexpected death in epilepsy (SUDEP), the leading cause of death in people with uncontrolled epileptic seizures.
Deep-brain stimulation (DBS) is the newest of three types of neuromodulation for epilepsy. Targeted electrical pulses inhibit a network in the brain involved in starting and spreading seizures. This interference is linked with a reduction in the number and/or severity of seizures.
First corpus callosotomy surgery performed at Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center
The 147th Annual Meeting of the American Neurological Association (taking place in-person October 22–25, 2022 in Chicago) will explore new frontiers in neurology, including climate change and the brain, lab-grown brain structures for studying disease, and addressing disparities in neurologic care.
Don't miss these articles in our Staff Picks channel
About 250,000 people in Ukraine have epilepsy, which requires daily medication. But supplies of anti-seizure medications are running low in Ukraine, and nearly 2 million people have fled into neighboring countries, with more likely to follow over the coming weeks.
A new study of brain development in mice shortly after birth may provide insights into how early life events can affect wiring patterns in the brain that manifest as disease later in life – specifically such disorders as schizophrenia, epilepsy and autism.
The brain is front and center during March, and experts from the Cedars-Sinai departments of Neurology & Neurosurgery are available for interviews about the latest research and treatments for neurological diseases and conditions, including multiple sclerosis, epilepsy and traumatic brain injuries.
Responsive neurostimulation is the latest advance offering hope for children with treatment-resistant epilepsy. For more than a third of children with epilepsy, medications are not enough to control their seizures. Surgery can be an excellent option for many of these treatment-resistant patients, but not every child is a good candidate.
Cleveland Clinic has launched an innovative study exploring the link between epilepsy and stress, supported by a $5.5 million donation from the Charles L. Shor Foundation. The five-year clinical trial is the first of its kind to study and compare the effect of lifestyle interventions, such as yoga, music therapy and cognitive behavioral therapy, on seizure control. The research team will study the impact on seizure frequency as well as epilepsy-associated co-morbidities, such as depression, anxiety, cognitive function and quality of life. The team will follow 1,000 patients with difficult-to-treat epilepsy.
UNLV-led research team identifies key brain protein to target for new customized drug therapies treating adverse symptoms of developmental disorder subtypes.
At least 1 in 4 people with epilepsy will experience anxiety, which can interfere with seizure control and impact quality of life. Epilepsy care providers are uniquely positioned to screen patients for anxiety and discuss treatment options.
The Department of Neurology at Texas Tech Physicians of El Paso is expanding telemedicine services and community education in rural West Texas.
University of Maryland School of Medicine researchers developed a technique in laboratory animals to consistently and reproducibly open the blood-brain barrier. Their paper essentially provides a roadmap for other researchers to develop and test new therapies for brain diseases.
Aleina and Kelly Milligan are more than sisters - they are truly best friends. For Kelly, her older sister has been a lifeline during the past two years. As Kelly settled in with her sister in Columbia, Kentucky, Aleina became concerned when she noticed a change in Kelly’s seizure patterns. The sisters then made the trip to Lexington for an appointment with UK HealthCare’s Sally Mathias, M.D., assistant professor of Neurology, who specializes in epilepsy.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
